Where pharmacy margin leaks — and why the NHS pays you weeks late
Two forces are quietly draining community pharmacy: margin leakage on the drugs you dispense, and a cashflow gap while you wait for the NHS to reimburse you. They compound each other. You buy stock today, dispense at a price set months ago by a formula you don't control, then wait weeks to get paid — often for less than the item cost you. Here's exactly where the money goes, and what operators can do about it.
6% profitable
Only 6% of pharmacy owners say their business is profitable — while 51% are operating at a loss (CPE Pressures Survey 2025).
6–10 weeks
The typical wait between paying suppliers for stock and receiving NHS reimbursement — bridged from the pharmacy's own pocket.
248 closures
Community pharmacies that closed in England in 2024 — nearly five every week.
It's rarely one big loss — it's thousands of small ones
Margin leakage is the gap between what a medicine costs you and what you're reimbursed, line by line, prescription by prescription. It stays hidden because most pharmacies only see it in aggregate, months late, in the year-end accounts. Three structural mechanics drive it:
The Drug Tariff sets your income, not the market
For 600+ generics, reimbursement is fixed by Category M of the Drug Tariff, recalculated quarterly to hit a national margin target (£1,100m in 2026/27). Prices are set in advance on estimated volumes and lag real market prices by three to six months — so today's reimbursement can reflect last year's wholesaler costs.
Clawback comes off the top
The NHS deducts an assumed discount from every payment — 20% on generics, 5% on brands, 9.85% on appliances — whether or not you actually achieved it. Buy badly on a generic and the clawback still assumes you bought well.
Concession lag forces dispensing at a loss
When supply tightens, purchase prices spike overnight but the price concession is not confirmed until month-end. One contractor cited aspirin 75mg jumping from 12p to £3.80 against an 88p concession — a guaranteed loss on every pack, with a legal duty to keep supplying (P3 Pharmacy).
A contract designed in 2005, never rebuilt for today's market
Reimbursement was designed when medicines supply — not clinical services — was the whole job. Each mechanism made sense in isolation; together, they leak. Reform is promised but slow, so the only lever you fully control is how tightly you manage your own buying and cash.
| Mechanism | What it was designed to do | Why it leaks now |
|---|---|---|
| Category M pricing | Deliver a fixed national margin pool | Set in advance; lags real prices by three to six months |
| Retrospective margin survey | Reconcile over- and under-delivery of margin | Downward repricing (e.g. −£16.8m/quarter, Jan 2026) hits cash long after purchase |
| Discount deduction | Standardise assumed buying gains | Punishes poor buying and volatile lines equally |
| Price concessions | Cover supply-driven price spikes | Confirmed too late to prevent loss-making dispensing |
Even where the margin works, the timing doesn't
You pay wholesalers on their terms — and those terms are tightening — but the NHS reimburses weeks after you've dispensed. In effect, pharmacies act as an interest-free credit facility for the NHS drugs bill.
The reimbursement gap
Pharmacies typically wait six to ten weeks between paying for stock and receiving NHS payment — financing the gap themselves the whole time.
Dipping into savings
Owners who used personal savings to keep the business afloat last year. 37% could not pay wholesaler bills on time; 60% took no salary.
Terms are tightening
Wholesalers have brought forward direct-debit collection dates, widening the gap further — the NPA warned ministers it is 'yet another pressure on already-stretched cashflow'.
Move the analysis forward — to the line, in near-real time
Margin leakage hides because it's reviewed in aggregate, after the money's gone. The fix is to bring the analysis forward to the point of dispensing:
Reconcile every line against the Tariff
Compare what you paid to what you'll be reimbursed per item, so loss-making lines surface the day they're dispensed — not at year-end.
Flag exceptions, don't read reports
You don't need another dashboard; you need the 30 lines this week that are bleeding money, ranked by impact.
Buy from margin, not habit
Route the next order to the supplier and pack size that protects margin after clawback — not the default on the account.
Close the cash gap
Where reimbursement lag is the binding constraint, settlement financing against confirmed NHS claims turns a six-to-ten-week wait into working capital you can use now.
See your margin. Get your cash.
Tenens is the operator console built for exactly this problem — a pharmacy financial operating system with two pillars, for pharmacies of every size, from independents to chains.
Margin engine
Ingests your PMR data, assesses margin risk line by line, and surfaces the exceptions quietly costing you — so procurement decisions get more disciplined.
Instant settlements (early access)
Addresses the reimbursement lag directly, helping you unlock cash tied up in confirmed NHS claims instead of bridging the gap from savings.
The numbers behind this guide
Figures on this page are drawn from published sector sources: CPE Pharmacy Pressures Survey 2025 (6% profitable, 51% at a loss, 45% used savings, 37% couldn't pay wholesalers, 60% no salary); Frontier Economics / IQVIA Economic Analysis (Mar 2025) (~47% not profitable, £2bn funding deficit); Pharmacy Business (248 closures in 2024); P3 Pharmacy (payment gap, concession lag); and Community Pharmacy England on Category M and discount deduction.
See where your margin is leaking — on your own data.
Margin leakage and the reimbursement gap are structural, but line by line they're measurable and fixable. Book a pilot and we'll show you where the money is going.